All In MedTech

Device Trial Radar · NCT02187770

Precision of IMED-4 Lung Fluid Measurements

Last checked: Nov 20, 2026Latest source record: Oct 14, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

46

Actual

Start

Jul 2014

Primary completion

Sep 2015

Study completion Oct 2015

Sponsor

Lead sponsor
Intersection Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jul 11, 2014

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if IMED-4 recordings have sufficient precision to detect a clinically significant change in lung fluid status in acute heart failure syndrome with pulmonary congestion.

Conditions

  • Dyspnea
  • Acute Heart Failure Syndrome
  • Pulmonary Congestion

Interventions

  • IMED-4Device

    Non invasive recording electrode used to assess lung fluid

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Lung Fluid StatusTime frame: Up to 1 year

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Mass General Hospital

    Boston, Massachusetts

  • Henry Ford Hospital

    Detroit, Michigan

  • Ohio State University

    Columbus, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.